Combinatorial RNAi: A winning strategy for the race against evolving targets?

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 878-888

  Grimm, Dirk ^a   Kay, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DOUBLE STRANDED RNA; LENTIVIRUS VECTOR; MICRORNA; PARVOVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

AUTOSOMAL DOMINANT DISORDER; CANCER; CLINICAL TRIAL; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENE TECHNOLOGY; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MONOTHERAPY; NONHUMAN; PROMOTER REGION; REVIEW; RNA INTERFERENCE; VIRAL GENE THERAPY; VIRUS INFECTION; VIRUS RESISTANCE;

ANIMALS; GENE THERAPY; GENETIC DISEASES, INBORN; HUMANS; MODELS, GENETIC; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 34247278567     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300116     Document Type: Review

References (84)

1. Grimm, D and Kay, MA (2006). Therapeutic short hairpin RNA expression in the liver: Viral targets and vectors. Gene Ther 13: 563-575.
2. UNAIDS (2006). Report on the global AIDS epidemic 2006. UNAIDS. .
3. Rambaut, A, Posada, D, Crandall, KA and Holmes, EC (2004). The causes and consequences of HIV evolution. Nat Rev Genet 5: 52-61.
4. Wieland, SF and Chisari, FV (2005). Stealth and cunning: Hepatitis B and hepatitis C viruses. J Virol 79: 9369-9380.
5. Couzin, J (2002). Breakthrough of the year. Small RNAs make big splash. Science 298: 2296-2297.
6. Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE and Mello, CC (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
7. Voinnet, O (2005). Induction and suppression of RNA silencing: Insights from viral infections. Nat Rev Genet 6: 206-220.
8. Cullen, BR (2006). Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 7: 563-567.
9. Lagos-Quintana, M, Rauhut, R, Meyer, I, Borkhardt, A and Tuschl, T (2003). New microRNAs from mouse and human. RNA 9: 175-179.
10. Hannon, GJ and Rossi, JJ (2004). Unlocking the potential of the human genome with RNA interference. Nature 431: 371-378.
11. Dykxhoorn, DM and Lieberman, J (2006). Silencing viral infection. PloS Med 3: E242.
12. Leonard, JN and Schaffer, DV (2006). Antiviral RNAi therapy: Emerging approaches for hitting a moving target. Gene Ther 13: 532-540.
13. Palliser, D, Chowdhury, D, Wang, QY, Lee, SJ, Bronson, RT, Knipe, DM et al. (2006). An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439: 89-94.
14. Bitko, V, Musiyenko, A, Shulyayeva, O and Barik, S (2005). Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 11 50-55.
15. Zeng, Y, Cai, X and Cullen, BR (2005). Use of RNA polymerase II to transcribe artificial microRNAs. Methods Enzymol 392: 371-380.
16. Grimm, D, Streetz, KL, Jopling, CL, Storm, TA, Pandey, K, Davis, CR et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
17. Lee, SK, Dykxhoorn, DM, Kumar, P, Ranjbar, S, Song, E, Maliszewski, LE et al. (2005). Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106: 818-826.
18. Kumar, P, Lee, SK, Shankar, P and Manjunath, N (2006). A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 3: E96.
19. Gitlin, L, Karelsky, S and Andino, R (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418: 430-434.
20. Gitlin, L, Stone, JK and Andino, R (2005). Poliovirus escape from RNA interference: Short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79: 1027-1035.
21. Randall, G, Grakoui, A and Rice, CM (2003). Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAS. Proc Natl Acad Sci USA 100: 235-240.
22. Wilson, JA and Richardson, CD (2005). Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol 79: 7050-7058.
23. Boden, D, Pusch, O, Lee, F, Tucker, L and Ramratnam, B (2003). Human immunodeficiency virus type 1 escape from RNA interference. J Virol 77: 11531-11535.
24. Das, AT, Brummelkamp, TR, Westerhout, EM, Vink, M, Madiredjo, M, Bernards, R et al. (2004). Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 78 2601-2605.
25. Westerhout, EM, Ooms, M, Vink, M, Das, AT and Berkhout, B (2005). HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33: 796-804.
26. Sarnow, P, Jopling, CL, Norman, KL, Schutz, S and Wehner, KA (2006). MicroRNAs: Expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol 4: 651-659.
27. Schutz, S and Sarnow, P (2006). Interaction of viruses with the mammalian RNA interference pathway. Virology 344: 151-157.
28. Cullen, BR (2006). Viruses and microRNAs. Nat Genet 38 (Suppl.): S25-S30.
29. Li, WX, Li, H, Lu, R, Li, F, Dus, M, Atkinson, P et al. (2004). Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci USA 101: 1350-1355.
30. Mathews, MB and Shenk, T (1991). Adenovirus virus-associated RNA and translation control. J Virol 65: 5657-5662.
31. Lu, S and Cullen, BR (2004). Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol 78: 12868-12876.
32. Andersson, MG, Haasnoot, PC, Xu, N, Berenjian, S, Berkhout, B and Akusjarvi, G (2005). Suppression of RNA interference by adenovirus virus-associated RNA. J Virol 79: 9556-9565.
33. Wang, Y, Kato, N, Jazag, A, Dharel, N, Otsuka, M, Taniguchi, H et al. (2006). Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 130: 883-892.
34. Bennasser, Y, Le, SY, Benkirane, M and Jeang, KT (2005). Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22: 607-619.
35. Bennasser, Y, Yeung, ML and Jeang, KT (2006). HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 281: 27674-27678.
36. Jopling, CL, Yi, M, Lancaster, AM, Lemon, SM and Sarnow, P (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
37. Pfeffer, S, Sewer, A, Lagos-Quintana, M, Sheridan, R, Sander, C, Grasser, FA et al. (2005). Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
38. Pfeffer, S, Zavolan, M, Grasser, FA, Chien, M, Russo, JJ, Ju, J et al. (2004). Identification of virus-encoded microRNAs. Science 304: 734-736.
39. Omoto, S and Fujii, YR (2005). Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol 86: 751-755.
40. Omoto, S and Fujii, YR (2006). Cloning and detection of HIV-1-encoded microRNA. Methods Mol Biol 342: 255-265.
41. Grundhoff, A, Sullivan, CS and Ganem, D (2006). A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12: 733-750.
42. Sullivan, CS, Grundhoff, AT, Tevethia, S, Pipas, JM and Ganem, D (2005). SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686.
43. Leonard, JN and Schaffer, DV (2005). Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol 79: 1645-1654.
44. Kronke, J, Kittler, R, Buchholz, F, Windisch, MP, Pietschmann, T, Bartenschlager, R et al. (2004). Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J Virol 78: 3436-3446.
45. Wang, Z, Ren, L, Zhao, X, Hung, T, Meng, A, Wang, J et al. (2004). Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells. J Virol 78: 7523-7527.
46. Kahana, R, Kuznetzova, L, Rogel, A, Shemesh, M, Hai, D, Yadin, H et al. (2004). Inhibition of foot-and-mouth disease virus replication by small interfering RNA. J Gen Virol 85: 3213-3217.
47. Song, E, Ren, L, Zhao, X, Hung, T, Meng, A, Wang, J et al. (2003). Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J Virol 77: 7174-7181.
48. Gonzalez, S, Castanotto, D, Li, H, Olivares, S, Jensen, MC, Forman, SJ et al. (2005). Amplification of RNAi - targeting HLA mRNAs. Mol Ther 11: 811-818.
49. Zhou, H, Xia, XG and Xu, Z (2005). An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi. Nucleic Acids Res 33: E62.
50. Xia, XG, Zhou, H, Samper, E, Melov, S and Xu, Z (2006). Pol II-expressed shRNA knocks dawn Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet 2: E10.
51. Sun, D, Melegari, M, Sridhar, S, Rogier, CE and Zhu, L (2006). Multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. Biotechniques 41: 59-63.
52. Chung, KH, Hart, CC, Al-Bassam, S, Avery, A, Taylor, J, Patel, PD et al. (2006). Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res 34: e53.
53. Yu, JY, Taylor, J. DeRuiter, SL, Vojtek, AB and Turner, DL (2003). Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol Ther 7: 228-236.
54. Jazag, A, Kanai, F, Ijichi, H, Tateishi, K, Ikenoue, T, Tanaka, Y et al. (2005). Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components. Nucleic Acids Res 33: E131.
55. Xia, XG, Zhou, H and Xu, Z (2006). Multiple shRNAs expressed by an inducible pol II promoter can knock down the expression of multiple target genes. Biotechniques 41: 64-68.
56. Shin, KJ, Wall, EA, Zavzavadjian, JR, Santat, LA, Liu, J, Hwang, JI et al. (2006). A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA 103: 13759-13764.
57. Zhang, J, Yamada, O, Sakamoto, T, Yoshida, H, Iwai, T, Matsushita, Y et al. (2004). Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus. Virology 320: 135-143.
58. Korf, M, Jarczak, D, Beger, C, Manns, MP and Kruger, M (2005). Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. J Hepatol 43: 225-234.
59. Henry, SD, van der Wegen, P, Metselaar, HJ, Tilanus, HW, Scholte, BJ and van der Laan, LJ (2006). Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther 14: 485-493.
60. Akashi, H, Miyagishi, M, Yokota, T, Watanabe, T, Hino, T, Nishina, K et al. (2005). Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol Biosyst 1: 382-390.
61. Watanabe, T, Sudoh, M, Miyagishi, M, Akashi, H, Arai, M, Inoue, K et al. (2006). Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther 13: 883-892.
62. Anderson, J, Banerjea, A and Akkina, R (2003). Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides 13: 303-312.
63. Lee, NS and Rossi, JJ (2004). Control of HIV-1 replication by RNA interference. Virus Res 102: 53-58.
64. Li, MJ, Bauer, G, Michienzi, A, Yee, JK, Lee, NS, Kim, J et al. (2003). Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 8: 196-206.
65. Chang, LJ, Liu, X and He, J (2005). Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther 12: 1133-1144.
66. ter Brake, O, Konstantinova, P, Ceylan, M and Berkhout, B (2006). Silencing of HIV-1 with RNA Interference: A Multiple shRNA Approach. Mol Ther 14: 883-892.
67. Nishitsuji, H, Kohara, M, Kannagi, M and Masuda, T (2006). Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration. J Virol 80: 7658-7666.
68. Hemmings-Mieszczak, M, Dom, G, Natt, FJ, Hall, J and Wishart, WL (2003). Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2×3 receptor. Nucleic Acids Res 31: 2117-2126.
69. Jarczak, D, Korf, M, Beger, C, Manns, MP and Kruger, M (2005). Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. FEBS J 272: 5910-5922.
70. Li, MJ, Kim, J, Li, S, Zaia, J, Yee, JK, Anderson, J et al. (2005). Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther 12: 900-909.
71. Unwalla, HJ, Li, HT, Bahner, I, Li, MJ, Kohn, D and Rossi, JJ (2006). Novel Poll II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein. J Virol 80: 1863-1873.
72. Samakoglu, S, Lisowski, L, Budak-Alpdogan, T, Usachenko, Y, Acuto, S, Di Marzo, R et al. (2006). A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol 24: 89-94.
73. Jackson, AL and Linsley, PS (2004). Noise amidst the silence: Off-target effects of siRNAs? Trends Genet 20: 521-524.
74. An, DS, Qin, FX, Auyeung, VC, Mao, SH, Kung, SK, Baltimore, D et al. (2006). Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol Ther 14: 494-504.
75. Fish, RJ and Kruithof, EK (2004). Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors. BMC Mol Biol 5: 9.
76. Persengiev, SP, Zhu, X and Green, MR (2004). Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10: 12-18.
77. Barik, S (2006). RNAi in moderation. Nat Biotechnol 24: 796-797.
78. Wiznerowicz, M, Szuic, J and Trono, D (2006). Tuning silence: conditional systems for RNA interference. Nat Methods 3: 682-688.
79. Unwalla, HJ, Li, MJ, Kim, JD, Li, HT, Ehsani, A, Alluin, J et al. (2004). Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat Biotechnol 22: 1573-1578.
80. Strayer, DS, Feitelson, M, Sun, B and Matskevich, AA (2005). Paradigms for conditional expression of RNA interference molecules for use against viral targets. Methods Enzymol 392: 227-241.
81. An, CI, Trinh, VB and Yokobayashi, Y (2006). Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction. RNA 12: 710-716.
82. Szulc, J, Wiznerowicz, M, Sauvain, MO, Trono, D and Aebischer, P (2006). A versatile tool for conditional gene expression and knockdown. Nat Methods 3: 109-116.
83. Mi, J, Zhang, X, Rabbani, ZN, Liu, Y, Su, Z, Vujaskovic, Z et al. (2006). H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res 34: 3577-3584.
84. McNamara, JO II, Andrechek, ER, Wang, Y, Viles, KD, Rempel, RE, Gilboa, E et al. (2006). Cell type-specific delivery of siRNAs with aptamer-sIRNA chimeras. Nat Biotechnol 24: 1005-1015.